Clinical Trial Update: A Study of Single Doses of ABT-072 in Japanese Healthy Male Adults [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating single doses of ABT-072 in healthy Japanese male adults, with Hepatitis C listed as the condition; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• ABT-072

Snippet

Sponsor: Abbott | Conditions: Hepatitis C | Phase 1 | Status: COMPLETED